News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
632,285 Results
Type
Article (39993)
Company Profile (153)
Press Release (592139)
Section
Business (175213)
Career Advice (2792)
Deals (34977)
Drug Delivery (95)
Drug Development (73322)
Employer Resources (160)
FDA (15741)
Job Trends (14809)
News (306596)
Policy (29735)
Tag
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (9)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2710)
Academic (1)
Accelerated approval (3)
Adcomms (23)
Allergies (84)
Alliances (44057)
ALS (89)
Alzheimer's disease (1397)
Antibody-drug conjugate (ADC) (103)
Approvals (15748)
Artificial intelligence (257)
Autoimmune disease (22)
Automation (14)
Bankruptcy (299)
Best Places to Work (12171)
BIOSECURE Act (17)
Biosimilars (97)
Biotechnology (107)
Bladder cancer (61)
Brain cancer (25)
Breast cancer (254)
Cancer (2004)
Cardiovascular disease (164)
Career advice (2316)
Career pathing (32)
CAR-T (143)
Cell therapy (420)
Cervical cancer (18)
Clinical research (59631)
Collaboration (788)
Compensation (463)
Complete response letters (20)
COVID-19 (2504)
CRISPR (37)
C-suite (223)
Cystic fibrosis (102)
Data (2001)
Decentralized trials (1)
Denatured (11)
Depression (39)
Diabetes (246)
Diagnostics (6621)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (39)
Drug discovery (124)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (83)
Earnings (68690)
Editorial (34)
Employer branding (21)
Employer resources (140)
Events (102176)
Executive appointments (676)
FDA (16879)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (703)
Gene editing (99)
Generative AI (23)
Gene therapy (291)
GLP-1 (644)
Government (4117)
Grass and pollen (4)
Guidances (46)
Healthcare (19968)
Huntington's disease (20)
IgA nephropathy (24)
Immunology and inflammation (103)
Indications (27)
Infectious disease (2634)
Inflammatory bowel disease (140)
Inflation Reduction Act (9)
Influenza (48)
Intellectual property (91)
Interviews (550)
IPO (16280)
IRA (37)
Job creations (3088)
Job search strategy (1920)
Kidney cancer (10)
Labor market (24)
Layoffs (440)
Leadership (19)
Legal (6721)
Liver cancer (63)
Lung cancer (280)
Lymphoma (126)
Machine learning (4)
Management (60)
Manufacturing (277)
MASH (63)
Medical device (14035)
Medtech (14040)
Mergers & acquisitions (19272)
Metabolic disorders (595)
Multiple sclerosis (72)
NASH (13)
Neurodegenerative disease (90)
Neuropsychiatric disorders (25)
Neuroscience (1895)
NextGen: Class of 2025 (6842)
Non-profit (4855)
Northern California (2478)
Now hiring (27)
Obesity (304)
Opinion (230)
Ovarian cancer (74)
Pain (85)
Pancreatic cancer (74)
Parkinson's disease (141)
Partnered (19)
Patents (208)
Patient recruitment (96)
Peanut (49)
People (52055)
Pharmaceutical (43)
Pharmacy benefit managers (18)
Phase I (18565)
Phase II (26419)
Phase III (19788)
Pipeline (1048)
Podcasts (44)
Policy (105)
Postmarket research (2084)
Preclinical (7568)
Press Release (62)
Prostate cancer (91)
Psychedelics (32)
Radiopharmaceuticals (260)
Rare diseases (371)
Real estate (5048)
Recruiting (63)
Regulatory (20816)
Reports (29)
Research institute (2470)
Resumes & cover letters (455)
Rett syndrome (4)
RNA editing (3)
RSV (41)
Schizophrenia (71)
Series A (122)
Series B (79)
Service/supplier (7)
Sickle cell disease (57)
Southern California (2160)
Special edition (14)
Spinal muscular atrophy (146)
Sponsored (26)
Startups (3196)
State (2)
Stomach cancer (7)
Supply chain (61)
The Weekly (32)
United States (21772)
Vaccines (620)
Venture capitalists (30)
Webinars (7)
Weight loss (191)
Women's health (27)
Worklife (17)
Date
Today (144)
Last 7 days (725)
Last 30 days (2844)
Last 365 days (35015)
2025 (8711)
2024 (36484)
2023 (41508)
2022 (52610)
2021 (57309)
2020 (55873)
2019 (49126)
2018 (37035)
2017 (32624)
2016 (30983)
2015 (36163)
2014 (25447)
2013 (20107)
2012 (21567)
2011 (22414)
2010 (19620)
Location
Africa (793)
Alabama (54)
Alaska (7)
Arizona (161)
Arkansas (12)
Asia (37262)
Australia (6575)
California (5630)
Canada (1888)
China (477)
Colorado (254)
Connecticut (268)
Delaware (130)
Europe (85829)
Florida (841)
Georgia (205)
Idaho (59)
Illinois (513)
India (20)
Indiana (301)
Iowa (8)
Japan (142)
Kansas (98)
Kentucky (26)
Louisiana (8)
Maine (69)
Maryland (836)
Massachusetts (4360)
Michigan (230)
Minnesota (375)
Mississippi (2)
Missouri (84)
Montana (31)
Nebraska (26)
Nevada (57)
New Hampshire (67)
New Jersey (1620)
New Mexico (30)
New York (1619)
North Carolina (985)
North Dakota (8)
Northern California (2478)
Ohio (200)
Oklahoma (14)
Oregon (35)
Pennsylvania (1275)
Puerto Rico (9)
Rhode Island (27)
South America (1131)
South Carolina (19)
South Dakota (1)
Southern California (2160)
Tennessee (95)
Texas (837)
Utah (175)
Virginia (137)
Washington D.C. (55)
Washington State (528)
West Virginia (3)
Wisconsin (53)
632,285 Results for "viatris acquired by meda ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Viatris to Report First Quarter 2025 Financial Results on May 8, 2025
March 31, 2025
·
1 min read
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
Press Releases
Idorsia and Viatris update their collaboration for selatogrel and cenerimod
February 26, 2025
·
4 min read
Press Releases
Viatris to Present at the Barclays 27th Annual Global Healthcare Conference
March 5, 2025
·
1 min read
Patents
Novo, Viatris Settle Ozempic Patent Row
Alongside the settlement, Novo and Viatris have asked the U.S. Patent and Trademark Office to terminate its review of the validity of the Danish drugmaker’s semaglutide patents.
October 8, 2024
·
2 min read
·
Tristan Manalac
Deals
Vitrolife AB (publ) acquires eFertility
Vitrolife AB signed an agreement to acquire 100% of the shares in eFertility. This acquisition is a key element of the Vitrolife Group’s strategy to bring increased standardisation and digitalisation to IVF clinics around the world.
May 2, 2024
·
2 min read
Press Releases
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
February 27, 2025
·
5 min read
Press Releases
Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance
February 27, 2025
·
46 min read
Deals
Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.
May 28, 2024
·
7 min read
Press Releases
Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 3, 2025
·
1 min read
1 of 63,229
Next
